Search results

Found 98 pages
AUTHOR: Bryony Andrews

Results per page

10 20 50 100

Sort by

Relevance Date

20 Aug 2021:

UK approves monoclonal antibody treatment for COVID-19

Regeneron/Roche's drug found to reduce hospitalisation - News - PharmaTimes

by Bryony Andrews|Bryony Andrews

www.pharmatimes.com/news/uk_approves_monoclonal_antibody_treatment_for_covid-19_1375472

2 Sep 2021:

JCVI advises booster COVID-19 jab for severely immunosuppressed

Offer is separate to potential booster programme - News - PharmaTimes

by Bryony Andrews|Bryony Andrews

www.pharmatimes.com/news/jcvi_advises_booster_covid-19_jab_for_severely_immunosuppressed_1376128

23 Aug 2021:

Valneva starts MHRA regulatory process for COVID-19 vaccine

VLA2001 is an inactivated, adjuvanted vaccine candidate - News - PharmaTimes

by Bryony Andrews|Bryony Andrews

www.pharmatimes.com/news/valneva_starts_mhra_regulatory_process_for_covid-19_vaccine_1375578

26 Aug 2021:

Home antibody tests for COVID-19 to be made available in UK

Up to 8,000 people per day can access the tests - News - PharmaTimes

by Bryony Andrews|Bryony Andrews

www.pharmatimes.com/news/home_antibody_tests_for_covid-19_to_be_made_available_in_uk_1375852

18 Aug 2021:

MHRA nod for Moderna’s COVID-19 vaccine for 12- to 17- year-olds

UK regulator confirms vaccine is “safe and effective” in this age group - News - PharmaTimes

by Bryony Andrews|Bryony Andrews

www.pharmatimes.com/news/mhra_nod_for_modernas_covid-19_vaccine_for_12-_to_17-_year-olds_1375309

27 Aug 2021:

NICE ‘no’ for Janssen’s Darzalex combo

Draft guidance shows concerns on cost-effectiveness of treatment - News - PharmaTimes

by Bryony Andrews

www.pharmatimes.com/news/nice_no_for_janssens_darzalex_combo_1375878

18 Aug 2021:

Accelerated FDA approval for GSK’s Jemperli

Indicated for the treatment of of dMMR recurrent or advanced solid tumours - News - PharmaTimes

by Bryony Andrews

www.pharmatimes.com/news/accelerated_fda_approval_for_gsks_jemperli_1375305

17 Aug 2021:

FDA fast tracks breast cancer candidate samuraciclib

Carrick Therapeutics’ oral CDK7 inhibitor may improve patient outcomes - News - PharmaTimes

by Bryony Andrews

www.pharmatimes.com/news/fda_fast_tracks_breast_cancer_candidate_samuraciclib_1375147

10 Aug 2021:

SMC approves Bavencio for bladder cancer

The treatment was not recommended by NICE for the NHS in England - News - PharmaTimes

by Bryony Andrews

www.pharmatimes.com/news/smc_approves_bavencio_for_bladder_cancer_1374570

27 Aug 2021:

ICR cancer drug NXP800 to enter Phase I trials

The investigational drug targets the HSF1 pathway - News - PharmaTimes

by Bryony Andrews

www.pharmatimes.com/news/icr_cancer_drug_nxp800_to_enter_phase_i_trials_1375877